DRMA CIK: 1853816

Dermata Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−5.69
FY22:
−8.83
FY23:
−6.41
FY24:
−11.2
FY25:
−7.76
Change from FY21 to FY25
millions USD
FY21:
16.0
FY22:
4.28
FY23:
7.61
FY24:
6.89
FY25:
12.1
millions USD
FY21:
10.3
FY22:
–
FY23:
–
FY24:
−4.28
FY25:
4.36

All amounts in millions USD Data source:SEC EDGAR